封面
市場調查報告書
商品編碼
2176486

人工智慧驅動的睡眠呼吸中止症檢測設備市場預測至2034年——全球產品類型、睡眠呼吸中止症類型、技術、應用、最終用戶和地區分析

AI-Enabled Sleep Apnea Detection Devices Market Forecasts to 2034 - Global Analysis By Product Type, Sleep Apnea Type, Technology, Application, End User and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 300+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據,全球人工智慧驅動的睡眠呼吸中止症檢測設備市場預計將在 2026 年達到 18 億美元,並在預測期內以 19.3% 的複合年成長率成長,到 2034 年達到 74 億美元。

人工智慧驅動的睡眠呼吸中止症檢測設備市場涵蓋智慧穿戴式感測器、攜帶式診斷設備、非接觸式監測技術以及整合人工智慧的睡眠評估系統,旨在識別睡眠阻塞型睡眠呼吸中止症、居家診斷需求的成長以及數位醫療技術的廣泛應用正在推動市場成長。生理訊號分析、機器學習和自動睡眠評分技術的進步正在提升檢測能力。對價格親民的睡眠診斷技術投入的增加也創造了更多機會。

睡眠呼吸中止症的盛行率不斷上升,以及對易於取得的診斷解決方案的需求日益成長。

睡眠呼吸中止症盛行率的不斷上升以及對便捷診斷方案日益成長的需求正在推動市場成長。人們對睡眠呼吸障礙及其與心血管和代謝併發症之間關聯的認知不斷提高,加速了早期篩檢的發展。傳統的院內睡眠檢測費用昂貴、資源有限且等待時間長。人工智慧設備支援對呼吸模式、血氧飽和度和睡眠相關生理訊號進行自動分析。攜帶式居家檢測和穿戴式監測技術的普及正在改善診斷的可及性。醫療保健的日益數位化進一步推動了市場需求。

基於人工智慧的睡眠呼吸中止症檢測在臨床準確性和監管方面的限制。

人工智慧驅動的睡眠呼吸中止症檢測在臨床準確性方面的局限性以及監管方面的挑戰阻礙了市場成長。穿戴式和非接觸式裝置可能因身體運動、感測器放置位置以及個體睡眠模式差異等因素而導致結果不一致。有些消費級技術僅提供篩檢指標,而非臨床檢驗的診斷。設備效能和演算法訓練資料集的差異也使結果解讀變得複雜。法規核准、保險覆蓋範圍限制和資料隱私要求是進一步的障礙。醫療機構可能要求在開始治療前進行睡眠測試以獲得明確診斷。

擴展家庭睡眠診斷和人工智慧整合穿戴監測平台

居家睡眠診斷和人工智慧整合穿戴監測平台的普及帶來了巨大的成長機會。醫療科技公司正在開發集呼吸監測、血氧飽和度評估和智慧睡眠模式分析於一體的緊湊型設備。對便利偵測日益成長的需求推動了這些裝置與智慧型手機、雲端平台和遠端醫療服務的整合。多模態生理感測和自動睡眠評分技術的進步正在改善診斷流程。睡眠診所、穿戴式科技製造商和數位醫療服務提供者之間的合作有望加速這些技術的商業化和普及應用。

人們對該演算法的可靠性以及與現有睡眠多導圖系統的競爭表示擔憂。

演算法可靠性以及與現有多導睡眠圖系統的競爭問題,對市場發展構成重大挑戰。人工智慧驅動的睡眠呼吸中止症檢測依賴於精確的生理測量、代表性的訓練資料集和檢驗的臨床演算法。假陰性篩檢結果可能導致診斷延誤,而假陽性觀察可能導致不必要的檢查增加。現有的多導睡眠圖仍然是全面睡眠評估的關鍵標準。網路安全風險和敏感健康資料的處理也是需要關注的問題。不斷變化的醫療設備法規以及消費級穿戴裝置之間的競爭也可能進一步影響市場接受度。

新型冠狀病毒(COVID-19)的影響:

新冠疫情導致睡眠醫學服務中斷,檢測延遲、預約受限、診斷機構服務減少。這些挑戰促使人們對攜帶式居家睡眠呼吸中止症檢測、遠端監測和數位化診斷流程產生了濃厚的興趣。醫療服務提供者探索利用連網型設備和自動化分析技術,在傳統檢測機構之外進行睡眠評估。然而,供應鏈中斷和選擇性診斷活動的減少影響了設備的普及。遠端醫療將繼續推動市場發展。

在預測期內,攜帶式家用睡眠呼吸中止症檢測設備細分市場預計將佔據最大的市場佔有率。

在預測期內,攜帶式家用睡眠呼吸中止監測設備預計將佔據最大的市場佔有率,這主要得益於消費者對便利、經濟高效且具有臨床支持的睡眠呼吸中止症評估日益成長的需求。這些設備無需在專業的睡眠檢測機構內即可監測特定的呼吸和生理參數,有助於識別需要進一步評估或治療的患者。人工智慧訊號分析和自動報告功能的整合正在提高診斷效率。遠端醫療服務的擴展以及符合條件的家用檢測可獲得保險報銷,正在推動此類設備的普及。此外,人們對睡眠呼吸中止症的認知不斷提高,也進一步促進了該細分市場的成長。

在預測期內,多模態生理訊號分析領域預計將呈現最高的複合年成長率。

在預測期內,由於使用多種生理指標進行全面睡眠評估的需求不斷成長,多模態生理訊號分析領域預計將呈現最高的成長率。這些系統透過結合呼吸訊號、血氧飽和度、心率變異性、運動模式和其他測量數據,提高了睡眠呼吸障礙檢測的準確性。與穿戴式感測器和攜帶式診斷平台的整合技術的進步正在推動創新。雖然機器學習和資料融合技術的進步可能會加速其應用,但臨床檢驗對於診斷應用仍然至關重要。

市佔率最大的地區:

在預測期內,北美預計將佔據最大的市場佔有率,這得益於其完善的睡眠醫學基礎設施、對醫療技術的巨額投資以及家用睡眠呼吸中止症檢測的日益普及。人工智慧驅動的睡眠評估正透過攜帶式診斷設備、數位健康平台和遠端患者監護服務在美國和加拿大蓬勃發展。人們對阻塞型睡眠呼吸中止症的認知不斷提高,以及對便利診斷途徑的需求日益成長,正在推動該地區的市場發展。睡眠診所、醫療設備製造商和醫療保健提供者之間的合作進一步鞏固了北美的市場地位。

複合年成長率最高的地區:

在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於醫療基礎設施的不斷完善、人們對睡眠障礙認知的提高以及互聯診斷技術的廣泛應用。睡眠醫療服務和數位健康舉措正在中國、印度、日本、韓國和澳洲蓬勃發展。不斷成長的醫療支出和對價格合理的居家檢測需求的增加正在推動技術的普及應用。穿戴式感測器、基於智慧型手機的監測以及人工智慧驅動的睡眠分析技術的進步預計將加速該地區的市場成長。

免費客製化服務:

所有購買此報告的客戶均可從以下免費自訂選項中選擇一項:

  • 企業概況
    • 對其他市場參與者(最多 3 家公司)進行全面分析
    • 對主要公司進行SWOT分析(最多3家公司)
  • 區域分類
    • 根據客戶的興趣,我們將提供主要國家的市場估算和預測,以及複合年成長率(註:需經可行性確認)。
  • 競爭性標竿分析
    • 根據產品系列、企業發展和策略聯盟對重點公司進行基準分析。

目錄

第1章:執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章:研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章:競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球人工智慧睡眠呼吸中止症檢測設備市場:依產品類型分類

  • 穿戴式睡眠呼吸中止症檢測設備
    • 腕戴式和智慧型手錶類型的設備
    • 指戴式及環狀設備
    • 皮膚黏附式和穿戴式感測器
  • 攜帶式家用睡眠呼吸中止症檢測設備
  • 非接觸式睡眠監測設備
  • 人工智慧整合睡眠多導圖系統
  • 相容智慧型手機的睡眠呼吸中止症檢測設備
  • 其他產品類型

第6章 全球人工智慧睡眠呼吸中止症偵測設備市場:依睡眠呼吸中止症類型分類

  • 阻塞型睡眠呼吸中止症
  • 中樞性睡眠呼吸中止症
  • 混合型睡眠呼吸暫停
  • 其他睡眠呼吸障礙

第7章 全球人工智慧睡眠呼吸中止症檢測設備市場:依技術分類

  • 機器學習和預測分析
  • 深度學習與神經網路
  • 光學脈搏波檢測法和周邊動脈張力測定
  • 聲學/呼吸訊號分析
  • 基於雷達和射頻(RF)的感測技術
  • 多模態生理訊號分析
  • 人工智慧驅動的自動睡眠評分
  • 其他技術

第8章 全球人工智慧睡眠呼吸中止症檢測設備市場:按應用領域分類

  • 睡眠呼吸中止症的篩檢和早期檢測
  • 睡眠呼吸中止症的臨床診斷
  • 居家睡眠呼吸中止症測試
  • 睡眠呼吸中止症嚴重程度評估
  • 長期睡眠和呼吸監測
  • 治療反應和後續觀察
  • 人口健康和高風險患者篩檢
  • 其他用途

第9章 全球人工智慧睡眠呼吸中止症檢測設備市場:按最終用戶分類

  • 醫院
  • 睡眠診所和診斷檢測機構
  • 家庭醫療保健服務提供者
  • 個人消費者
  • 門診部和專科診所
  • 學術和研究機構
  • 其他最終用戶

第10章 全球人工智慧睡眠呼吸中止症檢測設備市場:按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區(RoW)
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章:公司簡介

  • ResMed Inc.
  • Koninklijke Philips NV
  • ZOLL Medical Corporation(Itamar Medical)
  • Nox Medical
  • Compumedics Limited
  • Nihon Kohden Corporation
  • EnsoData, Inc.
  • Onera Health BV
  • Acurable Ltd.
  • Sunrise
  • Wesper
  • Sleepiz AG
  • Huxley Medical, Inc.
  • PranaQ Pte. Ltd.
  • SleepImage
  • Beacon Biosignals, Inc.
  • SOMNOmedics GmbH
  • Samsung Electronics Co., Ltd.
Product Code: SMRC41275

According to Stratistics MRC, the Global AI-Enabled Sleep Apnea Detection Devices Market is accounted for $1.8 billion in 2026 and is expected to reach $7.4 billion by 2034 growing at a CAGR of 19.3% during the forecast period. The AI-Enabled Sleep Apnea Detection Devices Market encompasses intelligent wearable sensors, portable diagnostic equipment, contactless monitoring technologies, and AI-integrated sleep assessment systems designed to identify sleep-disordered breathing. Increasing prevalence of obstructive sleep apnea, growing demand for home-based diagnosis, and expanding adoption of digital healthcare technologies are supporting market growth. Advancements in physiological signal analysis, machine learning, and automated sleep scoring improve detection capabilities. Growing investment in accessible sleep diagnostics creates additional opportunities.

Market Dynamics:

Driver:

Increasing prevalence of sleep apnea and demand for accessible diagnostic solutions

Increasing prevalence of sleep apnea and demand for accessible diagnostic solutions is driving market growth. Growing awareness of sleep-disordered breathing and its association with cardiovascular and metabolic complications encourages earlier screening. Conventional laboratory-based sleep studies may involve high costs, limited availability, and lengthy waiting periods. AI-enabled devices support automated analysis of respiratory patterns, oxygen saturation, and sleep-related physiological signals. Expanding adoption of portable home testing and wearable monitoring technologies improves diagnostic accessibility. Increasing healthcare digitalization further strengthens demand.

Restraint:

Clinical accuracy limitations and regulatory challenges in AI-based sleep apnea detection

Clinical accuracy limitations and regulatory challenges in AI-based sleep apnea detection restrain market growth. Wearable and contactless devices may produce inconsistent results due to movement artifacts, sensor placement, and variations in individual sleep patterns. Some consumer technologies provide screening indications rather than clinically validated diagnoses. Differences in device performance and algorithm training datasets complicate interpretation. Regulatory approval, reimbursement limitations, and data privacy requirements create additional barriers. Healthcare providers may require confirmatory sleep studies before initiating treatment.

Opportunity:

Expansion of home-based sleep diagnostics and AI-integrated wearable monitoring platforms

Expansion of home-based sleep diagnostics and AI-integrated wearable monitoring platforms presents significant growth opportunities. Healthcare technology companies are developing compact devices that combine respiratory monitoring, oxygen saturation assessment, and intelligent sleep pattern analysis. Growing demand for convenient testing encourages integration with smartphones, cloud platforms, and telehealth services. Advancements in multimodal physiological sensing and automated sleep scoring improve diagnostic workflows. Partnerships among sleep clinics, wearable technology manufacturers, and digital health providers are expected to accelerate commercialization and adoption.

Threat:

Algorithm reliability concerns and competition from established polysomnography systems

Algorithm reliability concerns and competition from established polysomnography systems pose significant challenges to market development. AI-enabled sleep apnea detection depends on accurate physiological measurements, representative training datasets, and validated clinical algorithms. False-negative screening results may delay diagnosis, while false-positive findings can increase unnecessary testing. Established polysomnography remains an important reference standard for comprehensive sleep assessment. Cybersecurity risks and sensitive health data handling create additional concerns. Evolving medical device regulations and competition among consumer wearables may further influence market adoption.

Covid-19 Impact:

The COVID-19 pandemic disrupted sleep medicine services through postponed laboratory studies, restricted clinical appointments, and reduced access to diagnostic facilities. These challenges increased interest in portable home sleep apnea testing, remote monitoring, and digital diagnostic workflows. Healthcare providers explored connected devices and automated analysis to maintain access to sleep assessments outside conventional laboratories. However, supply chain disruptions and reduced elective diagnostic activity affected device deployment. Post-pandemic expansion of telehealth and home-based diagnostic services continues to support market development.

The portable home sleep apnea testing devices segment is expected to be the largest during the forecast period

The portable home sleep apnea testing devices segment is expected to account for the largest market share during the forecast period due to increasing demand for convenient, cost-effective, and clinically supported sleep apnea assessment. These devices monitor selected respiratory and physiological parameters outside specialized sleep laboratories, helping identify patients requiring further evaluation or treatment. Growing integration of AI-based signal analysis and automated reporting improves diagnostic efficiency. Expanding telehealth services and reimbursement support for eligible home testing encourage adoption. Increasing sleep apnea awareness further strengthens segment growth.

The multimodal physiological signal analysis segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the multimodal physiological signal analysis segment is predicted to witness the highest growth rate due to increasing demand for comprehensive sleep assessment using multiple physiological indicators. These systems combine respiratory signals, oxygen saturation, heart rate variability, movement patterns, and other measurements to improve detection of sleep-disordered breathing. Growing integration with wearable sensors and portable diagnostic platforms encourages innovation. Advancements in machine learning and data fusion could accelerate adoption, although clinical validation remains essential for diagnostic applications.

Region with largest share:

During the forecast period, North America is expected to hold the largest market share due to established sleep medicine infrastructure, significant healthcare technology investment, and growing adoption of home sleep apnea testing. The United States and Canada are advancing AI-enabled sleep assessment through portable diagnostic devices, digital health platforms, and remote patient monitoring services. Increasing awareness of obstructive sleep apnea and demand for convenient diagnostic pathways encourage regional market development. Collaboration among sleep clinics, medical device manufacturers, and healthcare providers further strengthens North America's position.

Region with highest CAGR:

Over the forecast period, Asia Pacific is anticipated to exhibit the highest CAGR, supported by expanding healthcare infrastructure, increasing sleep disorder awareness, and growing adoption of connected diagnostic technologies. China, India, Japan, South Korea, and Australia are advancing sleep medicine services and digital health initiatives. Increasing healthcare expenditure and demand for affordable home-based testing encourage technology adoption. Improvements in wearable sensors, smartphone-enabled monitoring, and AI-assisted sleep analysis are expected to accelerate regional market growth.

Key players in the market

Some of the key players in the AI-Enabled Sleep Apnea Detection Devices Market include ResMed Inc., Koninklijke Philips N.V., ZOLL Medical Corporation (Itamar Medical), Nox Medical, Compumedics Limited, Nihon Kohden Corporation, EnsoData, Inc., Onera Health B.V., Acurable Ltd., Sunrise, Wesper, Sleepiz AG, Huxley Medical, Inc., PranaQ Pte. Ltd., SleepImage, Beacon Biosignals, Inc., SOMNOmedics GmbH, and Samsung Electronics Co., Ltd.

Key Developments:

In October 2026, Samsung Electronics Co., Ltd. announced regulatory approval in South Korea for an enhanced sleep apnea monitoring feature on compatible Galaxy wearables. The updated AI-based system analyzes breathing disturbances and provides more detailed risk information, supporting earlier identification of potential sleep-disordered breathing. The feature is intended for screening and does not replace professional diagnosis.

In September 2026, ResMed Inc. highlighted new research at the European Respiratory Society Congress examining sleep apnea care across the treatment journey. The initiative reflects growing industry attention to improved screening, patient identification, and personalized respiratory care, supporting the development of connected sleep health technologies.

In June 2026, Nox Medical highlighted advancements in AI-assisted sleep diagnostics through technologies designed to improve sleep staging, respiratory event analysis, and identification of obstructive sleep apnea. Its approach emphasizes more detailed physiological assessment using home sleep testing data, supporting improved clinical interpretation and personalized sleep care.

Product Types Covered:

  • Wearable Sleep Apnea Detection Devices
  • Portable Home Sleep Apnea Testing Devices
  • Contactless Sleep Monitoring Devices
  • AI-Integrated Polysomnography Systems
  • Smartphone-Enabled Sleep Apnea Detection Devices
  • Other Product Types

Sleep Apnea Types Covered:

  • Obstructive Sleep Apnea
  • Central Sleep Apnea
  • Mixed Sleep Apnea
  • Other Sleep-Disordered Breathing Conditions

Technologies Covered:

  • Machine Learning & Predictive Analytics
  • Deep Learning & Neural Networks
  • Photoplethysmography & Peripheral Arterial Tonometry
  • Acoustic & Respiratory Signal Analysis
  • Radar & Radiofrequency-Based Sensing
  • Multimodal Physiological Signal Analysis
  • AI-Based Automated Sleep Scoring
  • Other Technologies

Applications Covered:

  • Sleep Apnea Screening & Early Detection
  • Clinical Sleep Apnea Diagnosis
  • Home-Based Sleep Apnea Testing
  • Sleep Apnea Severity Assessment
  • Longitudinal Sleep & Respiratory Monitoring
  • Treatment Response & Follow-Up Monitoring
  • Population Health & High-Risk Patient Screening
  • Other Applications

End Users Covered:

  • Hospitals
  • Sleep Clinics & Diagnostic Laboratories
  • Home Healthcare Providers
  • Individual Consumers
  • Ambulatory & Specialty Clinics
  • Academic & Research Institutions
  • Other End Users

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
      • Saudi Arabia
      • United Arab Emirates
      • Qatar
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • Egypt
      • Morocco
      • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global AI-Enabled Sleep Apnea Detection Devices Market, By Product Type

  • 5.1 Wearable Sleep Apnea Detection Devices
    • 5.1.1 Wrist-Worn & Smartwatch Devices
    • 5.1.2 Finger-Worn & Ring-Based Devices
    • 5.1.3 Skin-Adhesive & Body-Worn Sensors
  • 5.2 Portable Home Sleep Apnea Testing Devices
  • 5.3 Contactless Sleep Monitoring Devices
  • 5.4 AI-Integrated Polysomnography Systems
  • 5.5 Smartphone-Enabled Sleep Apnea Detection Devices
  • 5.6 Other Product Types

6 Global AI-Enabled Sleep Apnea Detection Devices Market, By Sleep Apnea Type

  • 6.1 Obstructive Sleep Apnea
  • 6.2 Central Sleep Apnea
  • 6.3 Mixed Sleep Apnea
  • 6.4 Other Sleep-Disordered Breathing Conditions

7 Global AI-Enabled Sleep Apnea Detection Devices Market, By Technology

  • 7.1 Machine Learning & Predictive Analytics
  • 7.2 Deep Learning & Neural Networks
  • 7.3 Photoplethysmography & Peripheral Arterial Tonometry
  • 7.4 Acoustic & Respiratory Signal Analysis
  • 7.5 Radar & Radiofrequency-Based Sensing
  • 7.6 Multimodal Physiological Signal Analysis
  • 7.7 AI-Based Automated Sleep Scoring
  • 7.8 Other Technologies

8 Global AI-Enabled Sleep Apnea Detection Devices Market, By Application

  • 8.1 Sleep Apnea Screening & Early Detection
  • 8.2 Clinical Sleep Apnea Diagnosis
  • 8.3 Home-Based Sleep Apnea Testing
  • 8.4 Sleep Apnea Severity Assessment
  • 8.5 Longitudinal Sleep & Respiratory Monitoring
  • 8.6 Treatment Response & Follow-Up Monitoring
  • 8.7 Population Health & High-Risk Patient Screening
  • 8.8 Other Applications

9 Global AI-Enabled Sleep Apnea Detection Devices Market, By End User

  • 9.1 Hospitals
  • 9.2 Sleep Clinics & Diagnostic Laboratories
  • 9.3 Home Healthcare Providers
  • 9.4 Individual Consumers
  • 9.5 Ambulatory & Specialty Clinics
  • 9.6 Academic & Research Institutions
  • 9.7 Other End Users

10 Global AI-Enabled Sleep Apnea Detection Devices Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 ResMed Inc.
  • 13.2 Koninklijke Philips N.V.
  • 13.3 ZOLL Medical Corporation (Itamar Medical)
  • 13.4 Nox Medical
  • 13.5 Compumedics Limited
  • 13.6 Nihon Kohden Corporation
  • 13.7 EnsoData, Inc.
  • 13.8 Onera Health B.V.
  • 13.9 Acurable Ltd.
  • 13.10 Sunrise
  • 13.11 Wesper
  • 13.12 Sleepiz AG
  • 13.13 Huxley Medical, Inc.
  • 13.14 PranaQ Pte. Ltd.
  • 13.15 SleepImage
  • 13.16 Beacon Biosignals, Inc.
  • 13.17 SOMNOmedics GmbH
  • 13.18 Samsung Electronics Co., Ltd.

List of Tables

  • Table 1 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Wearable Sleep Apnea Detection Devices (2023-2034) ($MN)
  • Table 4 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Wrist-Worn & Smartwatch Devices (2023-2034) ($MN)
  • Table 5 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Finger-Worn & Ring-Based Devices (2023-2034) ($MN)
  • Table 6 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Skin-Adhesive & Body-Worn Sensors (2023-2034) ($MN)
  • Table 7 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Portable Home Sleep Apnea Testing Devices (2023-2034) ($MN)
  • Table 8 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Contactless Sleep Monitoring Devices (2023-2034) ($MN)
  • Table 9 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By AI-Integrated Polysomnography Systems (2023-2034) ($MN)
  • Table 10 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Smartphone-Enabled Sleep Apnea Detection Devices (2023-2034) ($MN)
  • Table 11 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Other Product Types (2023-2034) ($MN)
  • Table 12 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Sleep Apnea Type (2023-2034) ($MN)
  • Table 13 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Obstructive Sleep Apnea (2023-2034) ($MN)
  • Table 14 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Central Sleep Apnea (2023-2034) ($MN)
  • Table 15 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Mixed Sleep Apnea (2023-2034) ($MN)
  • Table 16 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Other Sleep-Disordered Breathing Conditions (2023-2034) ($MN)
  • Table 17 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Technology (2023-2034) ($MN)
  • Table 18 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Machine Learning & Predictive Analytics (2023-2034) ($MN)
  • Table 19 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Deep Learning & Neural Networks (2023-2034) ($MN)
  • Table 20 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Photoplethysmography & Peripheral Arterial Tonometry (2023-2034) ($MN)
  • Table 21 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Acoustic & Respiratory Signal Analysis (2023-2034) ($MN)
  • Table 22 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Radar & Radiofrequency-Based Sensing (2023-2034) ($MN)
  • Table 23 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Multimodal Physiological Signal Analysis (2023-2034) ($MN)
  • Table 24 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By AI-Based Automated Sleep Scoring (2023-2034) ($MN)
  • Table 25 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 26 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Application (2023-2034) ($MN)
  • Table 27 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Sleep Apnea Screening & Early Detection (2023-2034) ($MN)
  • Table 28 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Clinical Sleep Apnea Diagnosis (2023-2034) ($MN)
  • Table 29 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Home-Based Sleep Apnea Testing (2023-2034) ($MN)
  • Table 30 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Sleep Apnea Severity Assessment (2023-2034) ($MN)
  • Table 31 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Longitudinal Sleep & Respiratory Monitoring (2023-2034) ($MN)
  • Table 32 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Treatment Response & Follow-Up Monitoring (2023-2034) ($MN)
  • Table 33 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Population Health & High-Risk Patient Screening (2023-2034) ($MN)
  • Table 34 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 35 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 36 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 37 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Sleep Clinics & Diagnostic Laboratories (2023-2034) ($MN)
  • Table 38 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Home Healthcare Providers (2023-2034) ($MN)
  • Table 39 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Individual Consumers (2023-2034) ($MN)
  • Table 40 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Ambulatory & Specialty Clinics (2023-2034) ($MN)
  • Table 41 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Academic & Research Institutions (2023-2034) ($MN)
  • Table 42 Global AI-Enabled Sleep Apnea Detection Devices Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.